⚡ Quick Summary
This methodological review aims to systematically identify and categorize the control conditions used in interventional studies of large language model (LLM)-based chatbots in digital health. By evaluating the appropriateness of these controls, the study seeks to enhance the validity and reproducibility of findings in this rapidly evolving field.
🔍 Key Details
- 📊 Focus: Control conditions in LLM-based chatbot trials
- 🧩 Methodology: Systematic review following PRISMA-P guidelines
- ⚙️ Data Sources: PubMed, PsycINFO, CENTRAL, CINAHL, Scopus
- 📝 Registration: PROSPERO CRD420251246148
- 🔍 Review Process: Dual independent data extraction and screening
🔑 Key Takeaways
- 📊 LLM chatbots are increasingly used as patient-facing digital health tools.
- 💡 Control conditions in trials are often inconsistently defined, leading to potential biases.
- 🧪 Study aims to categorize control types and evaluate their methodological appropriateness.
- 📅 Eligible studies include various control conditions, from no control to active comparators.
- 🔄 Variability in control types may influence the direction of reported effects.
- 📈 Focus on meta-research to improve the design of future trials.
- 🌍 Implications for better matching of comparators in LLM chatbot evaluations.
- 🗓️ Scoping searches are complete; full screening is yet to commence.
📚 Background
The integration of large language models (LLMs) into healthcare has opened new avenues for patient engagement and support. However, the interactive nature of these chatbots can complicate causal inference in clinical trials. As LLMs become more prevalent, understanding the control strategies employed in their evaluation is crucial for ensuring the reliability and reproducibility of research findings.
🗒️ Study
This review protocol is designed to systematically investigate the control conditions used in studies evaluating LLM-based, patient-facing digital health interventions. Following the PRISMA-P guidelines, the study will analyze various control types, including waitlist, treatment-as-usual, and sham digital controls, to assess their methodological rigor and appropriateness.
📈 Results
As of now, the protocol has been registered in PROSPERO, and scoping searches have been completed. The full screening and data extraction processes are yet to begin, but the study aims to provide a comprehensive overview of control practices in LLM chatbot trials, which will be instrumental in guiding future research.
🌍 Impact and Implications
The findings from this review will serve as an empirical map of control practices in LLM chatbot trials, offering valuable insights for researchers and practitioners. By identifying and categorizing control conditions, the study aims to support the design of better-matched comparators, ultimately leading to more valid and interpretable evaluations as LLMs continue to diffuse into patient care.
🔮 Conclusion
This methodological review highlights the importance of rigorously evaluating control conditions in LLM-based chatbot trials. By addressing inconsistencies and biases in comparator strategies, the study aims to enhance the quality of research in this innovative field. As LLMs become integral to digital health, ensuring robust methodologies will be key to unlocking their full potential in patient care.
💬 Your comments
What are your thoughts on the role of control conditions in evaluating digital health interventions? We invite you to share your insights and engage in a discussion! 💬 Please leave your comments below or connect with us on social media:
Investigating Placebos and Controls Used in Large Language Model-Based Chatbot Intervention Trials: Protocol for a Methodological Review.
Abstract
BACKGROUND: Large language model (LLM)-based chatbots are rapidly being repurposed as patient-facing digital health tools. Their interactive, adaptive, and seemingly empathic behavior can heighten engagement and expectancy-nonspecific factors that complicate causal inference. Yet, comparator strategies in LLM trials are inconsistently defined and often undermatched (eg, minimal education vs highly engaging chatbots), risking biased effect estimates and poor reproducibility.
OBJECTIVE: The aim of this study was to systematically identify and categorize the control conditions used in interventional studies of LLM-based, patient-facing digital health interventions and to evaluate their methodological appropriateness. Secondary aims are to describe variability by health domain and study design and to explore whether control type/quality relates to the direction of reported effects.
METHODS: This protocol follows PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) and is registered in PROSPERO. Eligible studies are interventional designs that evaluate LLM-based, patient-facing digital health interventions; any control condition is eligible (including no control, waitlist, treatment-as-usual, attention/education, active comparator, or sham digital control). We will search PubMed, PsycINFO, CENTRAL, CINAHL, and Scopus for records from January 1, 2023, onward. All records will be managed and screened in Rayyan by 2 independent reviewers. Dual, independent data extraction will target study context, intervention details, and control-arm characteristics (typology, rationale, matching to nonspecifics, blinding, reporting). No formal risk-of-bias assessments are planned, as the focus is on meta-research.
RESULTS: At submission, the protocol is registered in PROSPERO and has received no specific funding. Scoping searches are complete; full screening and extraction have not yet commenced.
CONCLUSIONS: This review will provide an empirical map of control practices in LLM chatbot trials and guidance for designing better-matched comparators, supporting more valid and interpretable evaluations as LLMs diffuse into patient care.
TRIAL REGISTRATION: PROSPERO CRD420251246148; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251246148.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/90507.
Author: [‘Druart L’, ‘Faria V’, ‘Annoni M’, ‘Torous J’, ‘Pontén M’, ‘Blease C’]
Journal: JMIR Res Protoc
Citation: Druart L, et al. Investigating Placebos and Controls Used in Large Language Model-Based Chatbot Intervention Trials: Protocol for a Methodological Review. Investigating Placebos and Controls Used in Large Language Model-Based Chatbot Intervention Trials: Protocol for a Methodological Review. 2026; 15:e90507. doi: 10.2196/90507